← FDA Drug Approvals (Drugs@FDA)

TIVOZANIB

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SANDOZ INC · Approved 2026-05-14

Drug application

FDA Application #

ANDA220437

Application type

Abbreviated New Drug Application (Generic)

Brand name

TIVOZANIB

Generic name

Tivozanib

Active ingredients

TIVOZANIB

Dosage form

CAPSULE

Route

—

Marketing status

None (Tentative Approval)

Sponsor

SANDOZ INC

First approval

2026-05-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown